Value for money in disease management of benign prostatic hyperplasia.
Curtiss
Frederic R
FR
D000317:Adrenergic alpha-Antagonists / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016568:Drugs, Generic / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013449:Sulfonamides / Q000191:economics* / Q000627:therapeutic use; D000077409:Tamsulosin
D000317:Adrenergic alpha-Antagonists; D016568:Drugs, Generic; D013449:Sulfonamides; D000077409:Tamsulosin